How interferon changes cancerous blood stem cells
September 21, 2026
September 21, 2026
ITHACA, New York, Sept. 21 -- Cornell University posted the following news:
* * *
How interferon changes cancerous blood stem cells
*
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators.
Because the broad activity of interferon-alpha can . . .
* * *
How interferon changes cancerous blood stem cells
*
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells, according to a study by Weill Cornell Medicine investigators.
Because the broad activity of interferon-alpha can . . .